Importance of Biomarkers in Risk Stratification of Pulmonary Thromboembolism Patients


Babaoglu E., HASANOGLU H. C. , SENTURK A., KARALEZLI A., KILIC H., AYKUN G., ...More

JOURNAL OF INVESTIGATIVE MEDICINE, vol.62, no.2, pp.328-331, 2014 (SCI-Expanded) identifier identifier identifier

Abstract

Introduction: Patients with pulmonary thromboembolism (PTE) are classified into 3 groups according to the clinical risk factors associated with mortality. High-risk patients and some of the intermediate-risk patients should be treated immediately to decrease the high mortality risk. Although clinical risk level of PTE can be determined by using echocardiography to evaluate right ventricle overload and pulmonary artery pressure findings, it may not be available in all emergency settings.